IDDI at SRIW Life Sciences’ Workshop
Publié le
Join Everardo Saad, IDDI’s Medical Director for a deep dive in the future of healthcare at SRIW Life Sciences’ workshop…
IDDI at Eyecelerator AAO 2022
Publié le
Linda Danielson, Chief Operating Officer of IDDI is representing IDDI at this year’s Eyecelerator @ AAO 2022 in Chicago, USA…
IDDI speaking at Precision in Clinical Trials Summit 2022
Publié le
Join IDDI’s Sr. RTSM System Specialist Paul Vanbosterhaut in the Tag-team presentation at the Precision in Clinical Trials Summit 2022…
IDDI at BIOForward 2022
Publié le
We’re glad to present at this year’s BIOForward in Oxford, UK on September 27! Erik Falvey, Sr. Director Business Development…
IDDI at Fierce Biotech Summit 2022
Publié le
Meet IDDI’s expert at the Fierce Biotech Summit 2022 in Boston, MA from 19-20 September! Shruti Jituri, Director BD Western…
IDDI at Rocky Mountain Life Sciences Investor & Partnering Conference 2022
Publié le
Meet IDDI’s expert at the Rocky Mountain Life Sciences Investor & Partnering Conference 2022 in Vail, CO from 13-14 September!…
IDDI at SCDM 2022 Annual Conference
Publié le
Meet IDDI’s expert at the SCDM 2022 Annual Conference in San Antonio, Texas from 11-14 September! Vicky Martin, Sr. Director…
IDDI Newsletter – August 2022
Publié le
IDDI ANNOUNCES RTSM PARTNERSHIP WITH CLARIO By combining CLARIO RTSM know-how with IDDI’s statistical expertise, we ensure that your studies…
The Benefit-Risk Assessment of New Treatments: The Health Technology Assessment (HTA) Process
Publié le
September 22, 2022 | 5:00-6:00 PM CEST | 11:00 AM – 12:00 PM EDT ABSTRACT The increasing cost of new…
IDDI at PCMG 2022 Annual Outsourcing Assembly
Publié le
Meet IDDI’s expert at the PCMG 2022 Annual Outsourcing Assembly in Krakow, Poland from 7-9 September! Erik Falvey, Sr. Director…